Abstract
BackgroundIt is increasing attention about the risk of latent tuberculosis infection (LTBI) reactivation during the treatment of biologic agents for patients with rheumatoid arthritis. Taiwan rheumatology association recommend performing at...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
